GGrantIndex
← Leaderboards

Hong-Gang Wang

University Of South Florida

Google Scholar ↗PubMed ↗ORCID ↗
$14,593,079
Attributed
$15,494,814
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,529,647 · 11

By mechanism

P01$12,763,879 · 3
R01$11,994,690 · 6
R21$771,078 · 2

Top collaborators

Most similar at University Of South Florida

Same institution · by research overlap

Others in their field

Top investigators on “Apoptosis”

Research focus

ApoptosisMalignant NeoplasmsMediatingProteinsApoptoticCellsMolecularMembraneIn VitroCancer CellAutophagocytosisComplexBaseIn VivoCell DeathInhibitor/AntagonistVesicleStructureProtein FamilyTumor ProgressionAutophagosomeTumorLysosomesResponse

Grant awards (60)

Targeting extracellular vesicles in neuroblastoma$690,013
R01 · FY2025 · CA
Non-canonical Caspase-8 Activation on Autophagosomal Membranes$418,500
R01 · FY2025 · CA · contact PI
Autophagosome closure by the ESCRT machinery$347,987
R01 · FY2025 · GM · contact PI
Non-canonical Caspase-8 Activation on Autophagosomal Membranes$418,500
R01 · FY2024 · CA · contact PI
Autophagosome closure by the ESCRT machinery$348,013
R01 · FY2024 · GM · contact PI
Autophagosome closure by the ESCRT machinery$348,038
R01 · FY2023 · GM · contact PI
Autophagosome closure by the ESCRT machinery$348,062
R01 · FY2022 · GM · contact PI
Non-canonical Caspase-8 Activation on Autophagosomal Membranes$341,436
R01 · FY2022 · CA · contact PI
Autophagy Heterogeneity and Tumor Metastasis$417,005
R21 · FY2021 · CA · contact PI
Non-canonical Caspase-8 Activation on Autophagosomal Membranes$348,482
R01 · FY2021 · CA · contact PI
Autophagosome closure by the ESCRT machinery$312,246
R01 · FY2021 · GM · contact PI
Autophagosome closure by the ESCRT machinery$75,000
R01 · FY2021 · GM · contact PI
Non-canonical Caspase-8 Activation on Autophagosomal Membranes$348,555
R01 · FY2020 · CA · contact PI
Autophagosome closure by the ESCRT machinery$312,315
R01 · FY2020 · GM · contact PI
Non-canonical Caspase-8 Activation on Autophagosomal Membranes$338,167
R01 · FY2019 · CA · contact PI
Autophagosome closure by the ESCRT machinery$312,381
R01 · FY2019 · GM · contact PI
Non-canonical Caspase-8 Activation on Autophagosomal Membranes$348,696
R01 · FY2018 · CA · contact PI
Autophagosome closure by the ESCRT machinery$312,445
R01 · FY2018 · GM · contact PI
Targeted Sphingolipid Metabolism for Treatment of AML$2,019,502
P01 · FY2017 · CA
Targeting Sphingosine Kinase in AML$224,096
P01 · FY2017 · CA · contact PI
Targeted Sphingolipid Metabolism for Treatment of AML$2,019,502
P01 · FY2016 · CA
Targeting Sphingosine Kinase in AML$224,096
P01 · FY2016 · CA · contact PI
Targeted Sphingolipid Metabolism for Treatment of AML$2,077,502
P01 · FY2015 · CA
Apoptosis Mechanisms and Human Cancer$249,040
R01 · FY2015 · CA · contact PI
Targeting Sphingosine Kinase in AML$230,541
P01 · FY2015 · CA · contact PI
Targeted Sphingolipid Metabolism for Treatment of AML$1,929,328
P01 · FY2014 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$241,569
R01 · FY2014 · CA · contact PI
Targeting Sphingosine Kinase in AML$214,053
P01 · FY2014 · CA · contact PI
Targeted Sphingolipid Metabolism for Treatment of AML$1,988,999
P01 · FY2013 · CA · contact PI
Regulation of Autophagy and Tumorigenesis by Bif-1$293,448
R01 · FY2013 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$234,098
R01 · FY2013 · CA · contact PI
Targeting Sphingosine Kinase in AML$220,672
P01 · FY2013 · CA · contact PI
Targeting autophagy in the TME$187,685
R21 · FY2013 · CA · contact PI
Regulation of Autophagy and Tumorigenesis by Bif-1$312,178
R01 · FY2012 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$249,040
R01 · FY2012 · CA · contact PI
Targeting autophagy in the TME$166,388
R21 · FY2012 · CA · contact PI
Development of Small Molecule Antagonists of Bcl2/BclXL$319,887
P01 · FY2011 · CA · contact PI
Regulation of Autophagy and Tumorigenesis by Bif-1$312,178
R01 · FY2011 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$249,040
R01 · FY2011 · CA · contact PI
Development of Small Molecule Antagonists of Bcl2/BclXL$344,456
P01 · FY2010 · CA · contact PI
Regulation of Autophagy and Tumorigenesis by Bif-1$321,833
R01 · FY2010 · CA · contact PI
Development of Small Molecule Antagonists of Bcl2/BclXL$336,753
P01 · FY2009 · CA · contact PI
Regulation of Autophagy and Tumorigenesis by Bif-1$321,313
R01 · FY2009 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$249,739
R01 · FY2009 · CA · contact PI
Development of Small Molecule Antagonists of Bcl2/BclXL$311,885
P01 · FY2008 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$139,067
R01 · FY2008 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$128,510
R01 · FY2008 · CA · contact PI
Development of Small Molecule Antagonists of Bcl2/BclXL$302,607
P01 · FY2007 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$262,741
R01 · FY2007 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$270,588
R01 · FY2006 · CA · contact PI
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis$235,398
R01 · FY2006 · CA · contact PI
Apoptosis Mechanisms and Human Cancer$277,100
R01 · FY2005 · CA
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis$241,063
R01 · FY2005 · CA
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis$241,063
R01 · FY2004 · CA
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis$241,063
R01 · FY2003 · CA
POSTTRANSLATIONAL MODIFICATIONS OF BAD$186,679
R01 · FY2003 · CA
Mechanisms of Rad9 Mediated Checkpoints and Apoptosis$241,063
R01 · FY2002 · CA
POSTTRANSLATIONAL MODIFICATIONS OF BAD$181,241
R01 · FY2002 · CA
POSTTRANSLATIONAL MODIFICATIONS OF BAD$175,963
R01 · FY2001 · CA
POSTTRANSLATIONAL MODIFICATIONS OF BAD$170,839
R01 · FY2000 · CA